معرفی
Prof. Michael Xianfeng Chen is a Personal Chair of Therapeutic Engineering and Director of Industry Engagement at the School of Engineering, University of Edinburgh. He leads the Institute for Bioengineering, focusing on biomaterials, biomedical engineering, and nanomedicine. His research emphasizes drug delivery systems, microneedle technologies, and microfluidics, with significant contributions to vaccine delivery and nanotechnology-based therapies.
Education:
- DPhil in Materials Science, University of Oxford
- MSc in Chemistry, National University of Singapore
Research Interests: Prof. Chen’s work spans advanced drug delivery systems, antibacterial coatings, biodegradable nanomedicine, and cancer therapy. He pioneers technologies like diamond nanoneedle arrays and programmable optical window bonding for microfluidic devices. His inventions have led to patents and industry collaborations, notably with Vaxxas for microneedle vaccine platforms.
Grants & Awards:
- Funding from MRC, EPSRC, Cancer Research UK, and industry partners
- Listed as a top 2% global scientist (2021–2024)
- 12 granted patents and 15 patent applications
Advising & Outreach: Prof. Chen supervises PhD students and postdocs, offering scholarships through the University of Edinburgh and international programs. He actively engages in scientific community service, reviewing for top journals and serving as an associate editor for IET Nanobiotechnology.
Labs & Teams: His research group focuses on bioengineering and nanomedicine, with projects ranging from hydrogel formulations to biosensor development. Collaborations span academia and industry, addressing challenges in drug delivery and medical diagnostics.
